The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Abstract Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as alternatives to classical monotarget therapies and microRNAs are of particular interest in that regard. MicroRNA research has come a long way from their initial discovery to the cumulative appreciation...
Enregistré dans:
Auteurs principaux: | Hannah Walgrave, Lujia Zhou, Bart De Strooper, Evgenia Salta |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e43a11d9d7444dbc9f5e8a4b95efafba |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
par: Longfei Jia, et autres
Publié: (2021) -
Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
par: Yanyan Jiang, et autres
Publié: (2021) -
Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis
par: Gerrit M. Grosse, et autres
Publié: (2021) -
MicroRNA-27b Expression in Rats Submitted to Physical Exercise and Experimental Cerebral Ischemia
par: De-Russi,Brenno Marco, et autres
Publié: (2021) -
MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure
par: Huatao Zhou, et autres
Publié: (2021)